KORIŤÁKOVÁ, Eva, Irena DOLEŽALOVÁ, Jan CHLÁDEK, Tereza JURKOVÁ, Jan CHRASTINA, Filip PLESINGER, Robert ROMAN, Martin PAIL, Pavel JURAK, Daniel Joel SHAW and Milan BRÁZDIL. A Novel Statistical Model for Predicting the Efficacy of Vagal Nerve Stimulation in Patients With Epilepsy (Pre-X-Stim) Is Applicable to Different EEG Systems. Frontiers in Neuroscience. Lausanne: Frontiers Media S.A., 2021, vol. 15, May, p. 1-6. ISSN 1662-453X. Available from: https://dx.doi.org/10.3389/fnins.2021.635787.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name A Novel Statistical Model for Predicting the Efficacy of Vagal Nerve Stimulation in Patients With Epilepsy (Pre-X-Stim) Is Applicable to Different EEG Systems
Authors KORIŤÁKOVÁ, Eva (203 Czech Republic, belonging to the institution), Irena DOLEŽALOVÁ (203 Czech Republic, belonging to the institution), Jan CHLÁDEK (203 Czech Republic, belonging to the institution), Tereza JURKOVÁ (203 Czech Republic, belonging to the institution), Jan CHRASTINA (203 Czech Republic, belonging to the institution), Filip PLESINGER (203 Czech Republic), Robert ROMAN (203 Czech Republic, belonging to the institution), Martin PAIL (203 Czech Republic, belonging to the institution), Pavel JURAK (203 Czech Republic), Daniel Joel SHAW (826 United Kingdom of Great Britain and Northern Ireland, belonging to the institution) and Milan BRÁZDIL (203 Czech Republic, guarantor, belonging to the institution).
Edition Frontiers in Neuroscience, Lausanne, Frontiers Media S.A. 2021, 1662-453X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30103 Neurosciences
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.152
RIV identification code RIV/00216224:14110/21:00120112
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3389/fnins.2021.635787
UT WoS 000653635600001
Keywords in English vagal nerve stimulation; neurostimulation; epilepsy; efficacy prediction; EEG reactivity; epilepsy treatment
Tags 14110127, 14110131, 14119612, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 23/7/2021 13:54.
Abstract
Background: Identifying patients with intractable epilepsy who would benefit from therapeutic chronic vagal nerve stimulation (VNS) preoperatively remains a major clinical challenge. We have developed a statistical model for predicting VNS efficacy using only routine preimplantation electroencephalogram (EEG) recorded with the TruScan EEG device (Brazdil et al., 2019). It remains to be seen, however, if this model can be applied in different clinical settings. Objective: To validate our model using EEG data acquired with a different recording system. Methods: We identified a validation cohort of eight patients implanted with VNS, whose preimplantation EEG was recorded on the BrainScope device and who underwent the EEG recording according to the protocol. The classifier developed in our earlier work, named Pre-X-Stim, was then employed to classify these patients as predicted responders or non-responders based on the dynamics in EEG power spectra. Predicted and real-world outcomes were compared to establish the applicability of this classifier. In total, two validation experiments were performed using two different validation approaches (single classifier or classifier voting). Results: The classifier achieved 75% accuracy, 67% sensitivity, and 100% specificity. Only two patients, both real-life responders, were classified incorrectly in both validation experiments. Conclusion: We have validated the Pre-X-Stim model on EEGs from a different recording system, which indicates its application under different technical conditions. Our approach, based on preoperative EEG, is easily applied and financially undemanding and presents great potential for real-world clinical use.
Links
NV19-04-00343, research and development projectName: Predikce Efektu Stimulace u pacientů s Epilepsií (PRESEnCE) (Acronym: PRESEnCE)
Investor: Ministry of Health of the CR
PrintDisplayed: 26/4/2024 20:39